Date: Fri, 18 Dec 98 00:01:55 EST From: salu8@webwork.co.jp To: pol90@worldnet.att.net Subject: SNN ALERT Message-ID: <359DFE77.4AC9@erols.com>
next in thread | raw e-mail | index | archive | help
December 17, 1998 StockNetworking News - Alert News Release - NuOncology Labs Inc. Symbol NLAB - OTC Bulletin Board The company has made a significant News Release regarding the validation of the company's drug, Arglabin, as a Farnesyl Transferase Inhibitor (FTI). The full text of the release can be viewed at: http://biz.yahoo.com/bw/981217/nuoncology_1.html To be removed as a SNN subscriber please put 'delete' in the subject of an empty e-mail and send it to: 4621@usa.net copyright SNN 1998 To Unsubscribe: send mail to majordomo@FreeBSD.org with "unsubscribe freebsd-doc" in the body of the message
Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?359DFE77.4AC9>